Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway

• Kristin G.-I. Mohn ,

  * E-mail: Kristin.Mohn@uib.no (KGIM); Siri.Mjaaland@fhi.no (SM)

  Affiliations The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway, Infectious Diseases Unit, Department of Internal Medicine, Haukeland University Hospital, Bergen, Norway, K.G. Jebsen Centre for Influenza Vaccine Research, Department of Clinical Science, University of Bergen, Bergen, and The Norwegian Institute of Public Health, Oslo, Norway

  ⨯
• Rebecca Jane Cox,

  Affiliations The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway, Department of Research & Development, Haukeland University Hospital, Bergen, Norway, K.G. Jebsen Centre for Influenza Vaccine Research, Department of Clinical Science, University of Bergen, Bergen, and The Norwegian Institute of Public Health, Oslo, Norway

  ⨯
• Gro Tunheim,

  Affiliations Division of Infectious Disease Control, Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway, K.G. Jebsen Centre for Influenza Vaccine Research, Department of Clinical Science, University of Bergen, Bergen, and The Norwegian Institute of Public Health, Oslo, Norway

  ⨯
• Jan Erik Berdal,

  Affiliation Department of Infectious Diseases, Akershus University Hospital, Nordbyhagen, Norway

  ⨯
• Anna Germundsson Hauge,

  Affiliations Section for Virology, Department of Laboratory Services, Norwegian Veterinary Institute, Oslo, Norway, Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway

  ⨯
• Åsne Jul-Larsen,

  Affiliation The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway

  ⨯
• Norwegian Pandemic Group ,

  ¶Membership of the Norwegian Pandemic Group is listed in the Acknowledgments.

  ⨯
• Bjoern Peters,

  Affiliation Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

  ⨯
• Fredrik Oftung,

  Affiliations Division of Infectious Disease Control, Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway, K.G. Jebsen Centre for Influenza Vaccine Research, Department of Clinical Science, University of Bergen, Bergen, and The Norwegian Institute of Public Health, Oslo, Norway

  ⨯
• Christine Monceyron Jonassen ,

  Contributed equally to this work with: Christine Monceyron Jonassen, Siri Mjaaland

  Affiliations Genetic Unit, Department of Multidisciplinary Laboratory Medicine and Medical Biochemistry, Akershus University Hospital, Nordbyhagen, Norway, Genetic Unit, Centre for Laboratory Medicine, Østfold Hospital Trust, Fredrikstad, Norway, Department of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Ås, Norway

  ⨯
• Siri Mjaaland

  Contributed equally to this work with: Christine Monceyron Jonassen, Siri Mjaaland

  * E-mail: Kristin.Mohn@uib.no (KGIM); Siri.Mjaaland@fhi.no (SM)

  Affiliations Division of Infectious Disease Control, Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway, K.G. Jebsen Centre for Influenza Vaccine Research, Department of Clinical Science, University of Bergen, Bergen, and The Norwegian Institute of Public Health, Oslo, Norway

  ⨯